pharma · Glaucoma · Macular Edema
Allergan Pharmaceuticals International
Allergan Pharmaceuticals International Limited
Allergan Pharmaceuticals International is a pharma organization headquartered in Dublin, IE. Primary therapeutic focus areas include Glaucoma, Macular Edema, Macular Degeneration, Dry Eye Syndromes, Choroid Neovasculariz
Dublin, IE HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dublin, IE
- Programs
- 13
- Drugs
- 15
- Patents
- 25
XEN45
Phase 3 · other · Glaucoma
XEN45 for Glaucoma is a Phase 3 program (other) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).
Internal code 1924-701-007
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Allergan Pharmaceuticals International Limited
- Phase
- Phase 3
- Modality
- other
- Indication
- Glaucoma
- Status
- completed
- Trials
- 1